Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

NCT01724580 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eli Lilly and Company